All subjects | Group 1 30 mg edoxaban plus 2.5 mg prasugrel | Group 2 30 mg edoxaban plus 3.75 mg prasugrel | |
---|---|---|---|
n = 24 | n = 12 | n = 12 | |
Age (years) | |||
Mean (SD) | 72 (4) | 71 (4) | 73 (3) |
65 to < 75, n (%) | 16 (66.7) | 9 (75.0) | 7 (58.3) |
75 to 80, n (%) | 8 (33.3) | 3 (25.0) | 5 (41.7) |
Height (cm) | |||
Mean (SD) | 164.0 (5.7) | 162.5 (5.7) | 165.5 (5.6) |
Weight (kg) | |||
Mean (SD) | 56.4 (2.2) | 55.8 (2.4) | 57.0 (1.9) |
> 50 to 60, n (%) | 24 (100.0) | 12 (100.0) | 12 (100.0) |
BMI (kg/m2) | |||
Mean (SD) | 21.1 (1.6) | 21.3 (1.6) | 21.0 (1.6) |
eGFR (mL/min/1.73m2) | |||
Mean (SD) | 73.5 (7.0) | 75.5 (6.6) | 71.6 (7.1) |
60 to < 90, n (%) | 24 (100.0) | 12 (100.0) | 12 (100.0) |
CLcr(mL/min) | |||
Mean (SD) | 67.2 (7.2) | 68.7 (6.1) | 65.8 (8.1) |
≥50, n (%) | 24 (100.0) | 12 (100.0) | 12 (100.0) |
Medical historya | |||
No, n (%) | 10 (41.7) | 5 (41.7) | 5 (41.7) |
Yes, n (%) | 14 (58.3) | 7 (58.3) | 7 (58.3) |